|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:acquired_by
|
gptkb:Pfizer
|
|
gptkbp:acquisition_year
|
gptkb:2009
|
|
gptkbp:employees
|
approximately 50,000
|
|
gptkbp:founded
|
1860
|
|
gptkbp:founder
|
John Wyeth
|
|
gptkbp:global_presence
|
operates in over 60 countries
|
|
gptkbp:headquarters
|
gptkb:Madison,_New_Jersey
gptkb:New_Jersey
|
|
gptkbp:healthcare
|
prescription drugs
vaccines
biologics
therapeutics
over-the-counter products
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Wyeth Pharmaceuticals
|
|
gptkbp:industry
|
gptkb:pharmaceuticals
|
|
gptkbp:key_people
|
gptkb:David_J._Hager
Robert Essner
Bernard Poussot
|
|
gptkbp:merged_with
|
gptkb:2002
American Home Products Corporation
|
|
gptkbp:notable_products
|
gptkb:Enbrel
gptkb:Forteo
gptkb:Effexor_XR
gptkb:Procrit
gptkb:Rebetol
Prevnar
Depo-Provera
Zosyn
Xyntha
Brevibloc
|
|
gptkbp:parent_company
|
gptkb:Pfizer_Inc.
|
|
gptkbp:parent_organization
|
gptkb:Pfizer_Inc.
|
|
gptkbp:products
|
nutritional products
vaccines
biopharmaceuticals
prescription medications
|
|
gptkbp:research_areas
|
oncology
central nervous system
infectious diseases
immunology
cardiovascular
|
|
gptkbp:revenue
|
$23 billion (2008)
|
|
gptkbp:subsidiaries
|
Wyeth Biopharma
Wyeth Consumer Healthcare
Wyeth Nutrition
Wyeth Pharmaceuticals LLC
Wyeth Research
|
|
gptkbp:type
|
gptkb:subsidiary
|
|
gptkbp:website
|
www.wyeth.com
|
|
gptkbp:bfsParent
|
gptkb:Mylotarg
|
|
gptkbp:bfsLayer
|
5
|